Statistics
Last Updated
Jun 9, 2026
Table of contents
Remote patient monitoring, using connected devices to track health data outside the clinic, has gone from a pandemic-era workaround to a core part of how chronic conditions are managed. Adoption and reimbursement are both climbing fast. Continuous glucose monitors are one familiar example of the broader category. Here is remote patient monitoring by the numbers, updated for 2026.
The headline numbers
Remote monitoring in four figures.
Market size
A market tripling this decade.
The global remote patient monitoring market was roughly $43 billion in 2024 and about $48 billion in 2025, on track to reach around $137 billion by 2033 at a steady low-teens growth rate. The aging population, the rising chronic-disease burden, and a clear shift toward care delivered at home are all pushing it.
Global remote patient monitoring market, in US dollars. Source: Straits Research. Estimates vary by source; other reports place 2024 between $28 billion and $43 billion.
Reimbursement
Medicare turned it on, and spending exploded.
The clearest sign of how fast remote monitoring took hold is in the Medicare data. After Medicare began covering RPM in 2018, annual spending jumped roughly twentyfold in three years, from about $15 million in 2019 to more than $300 million in 2022, with over 570,000 enrollees using the services. Providers can now bill in the range of $30 to $100 per patient per month.
Annual Medicare spending on remote patient monitoring, roughly a twentyfold rise in three years, with more than 570,000 enrollees using RPM. Source: Persistence Market Research, CMS.
Where it goes next
From sick care to continuous care.
The growth rests on a simple mismatch: nearly 129 million Americans live with at least one chronic disease, and managing those conditions with occasional office visits leaves long blind spots between appointments. Remote monitoring fills them. Cardiology is the largest use today, with diabetes and hypertension close behind, and the patient count is still climbing, one projection puts global RPM users at more than 115 million by 2027. Continuous glucose monitoring is the version most people have encountered, but the same model, a connected device feeding real numbers to a care team, is spreading across nearly every chronic condition.
Sources: Straits Research and MarketsandMarkets (market size); Persistence Market Research and Prevounce (US patient adoption and Medicare data); the US Centers for Medicare and Medicaid Services; and the CDC (chronic disease prevalence). Figures are current as of 2026 and rounded. Market-size estimates vary by source.
Lifelong Optimization
Not your average
Checkup
Every life stage brings new biological demands. Tracking the right metrics at the right time helps you adapt, optimize performance, and extend both lifespan and healthspan.
Traditional
Manual Data Processing
Guesswork Trend Detection
Slow Campaign Setup
Multiple Tools, Multiple Logins
Reactive Decision-Making
Manual Reporting
Delayed Results
High Error Risk
Automated Data Sync
Real-Time Trend Insights
Instant AI Optimization
All-in-One Platform
Proactive AI-Driven Strategies
Auto-Generated Reports
Instant Performance Updates
AI Precision
Frequently Asked Questions
Clarity before
you commit
Answers on setup, scale, and support to remove blockers.
